Crossmark

The distinct role of CD73 in the progression of pancreatic cancer

Crossref DOI link: https://doi.org/10.1007/s00109-018-01742-0

Published Online: 2019-03-29

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhou, Liangjing

Jia, Shengnan

Chen, Yan

Wang, Weiming

Wu, Zhengrong

Yu, Weihua

Zhang, Mingjie

Ding, Guoping

Cao, Liping http://orcid.org/0000-0003-4810-1495
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81772548)

Major Research Project of Science Technology Department of Zhejiang Province (2015C03G2010160)

Foundation Project for Medical Science and Technology of Zhejiang province (2015KYB218, 2018KY102)
License Information

Text and Data Mining valid from 2019-03-29
More Information

Article History

Received: 6 October 2018

Revised: 9 December 2018

Accepted: 26 December 2018

First Online: 29 March 2019

Compliance with ethical standards

: Animal experiments were approved and performed in accordance with the institutional guidelines for animal care of animal ethics committee of Zhejiang University, and the study protocols met the standards set by the Declaration of Helsinki and were approved by the Research Ethics Committee of Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University.

: The authors declare that they have no conflict of interest.